2. Academic Validation
  3. Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome?

Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome?

  • Hypertension. 2009 Oct;54(4):710-2. doi: 10.1161/HYPERTENSIONAHA.109.138883.
Gian Paolo Rossi
PMID: 19687342 DOI: 10.1161/HYPERTENSIONAHA.109.138883
Figures
Products